A Behavioral Intervention for Depression and Chronic Pain in Primary Care
CompletedNot applicableNCT03265210
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Chronic pain and depression frequently co-exist in late and mid-life and contribute to increased disability, high health care costs, psychiatric comorbidity, and suicide. The investigators will recruit 60 adults from Weill Cornell Medical Associates primary care practices; participants will be randomized to either Relief (a 9 session behavioral intervention) or usual care/referral for mental health care. Research assessments are conducted with both groups at study entry (Baseline), 6, 9, and 12 weeks.
Study details
- Official title
- "Relief": A Behavioral Intervention for Depression and Chronic Pain in Primary Care
- Conditions
- Interventions
- Behavioral: RELIEF
- Sponsor
- Weill Medical College of Cornell University
- Collaborators
- National Institute of Mental Health (NIMH)
- Start date
- 2018-02-01
- Primary completion
- 2022-02-22
- Sex
- All
- Age range
- from 50 Years
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- United States
- Total sites listed
- 3
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Age 50 years * PHQ-9 greater than or equal to 10 * Non-cancer related chronic pain, defined as pain during most days over the past 3 months by patient report * Capacity to consent Exclusion Criteria: * DSM-5 Axis 1 other than depression and anxiety disorders * Montreal Cognitive Assessment (MoCA) \< 24 * Active suicidal ideation, i.e. MADRS Suicide Item greater than or equal to 4 * Severe or life-threatening medical illness. * Patients on psychotropics, opioids or benzodiazepines will be included if they do not meet DSM-5 criteria for opioid, anxiolytics or other substance abuse disorders
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03265210